Background {#Sec1}
==========

Pancreaticoduodenectomy (PD) is a standard procedure for treating malignancy in the pancreatic head and periampullary area. Because PD includes anastomoses, which requires an advanced surgical technique, the mortality rates associated with this procedure in the past few decades have been reported to be approximately 25--30% \[[@CR1]\]. Although the mortality rate of patients undergoing PD has recently decreased owing to improvements in surgical techniques and perioperative management strategies, the postoperative morbidity rate is still as high as 40--50% \[[@CR2]\]. One of the major complications of PD has been leakage from pancreaticoenteric anastomosis.

This morbidity frequently leads to a fatal course, because the leaked pancreatic juice may affect the surrounding structures. Digestive enzymes in the leaked fluid can also disrupt the other anastomoses (i.e., gastroenterostomy, enteroenterostomy, or choledochoenterostomy) and sometimes cause massive hemorrhage by eroding the vessels. These conditions delay the initiation of adjuvant chemotherapy, and eventually yielding poor long-term results, even though recent technologies provide effective interventions for controlling diverse complications. Thus, several procedures associated with PD have been investigated, with a focus on leakage prevention.

Strategies for preventing the incidence of pancreatic fistulas are divided into two categories. The first category includes procedures that reinforce the consistency of anastomosis. These are related to the methodology of anastomosis or pathway of pancreatic juice. There is no consensus regarding the clinical effectiveness of this category of strategies. For example, whether the dunking technique is superior or inferior to duct-to-mucosa anastomosis during pancreaticojejunostomy (PJ) cannot be concluded \[[@CR3]\]. In addition, although recent studies showed the advantage of pancreaticogastrostomy (PG) over PJ in reducing the incidence of pancreatic fistula, no consensus has been reached regarding the issues of morbidity and mortality \[[@CR4], [@CR5]\].

Meanwhile, the second category includes several procedures that reduce the burden of pancreaticoenteric anastomosis. Some of these procedures are associated with the preoperative or intraoperative conditioning of the biliary tree, and others with stabilizing the anastomoses by special reconstruction methods. Still, others involve pancreatic or biliary decompression using the external drainage. In this regard, in June 2012, we introduced retrograde installation of percutaneous transhepatic negative-pressure biliary drainage (RPTNBD) for biliopancreatic decompression in patients who had undergone PD for malignant disease (i.e., duodenal cancer, pancreatic cancer, bile duct cancer, and other malignant conditions requiring PD for R0 resection). Preoperatively, endoscopic nasobiliary drainage (ENBD) was applied for biliary decompression. This novel procedure could minimize the leakage rates of pancreaticoenterostomy and decompress both PJ and choledochojejunostomy (CJ) simultaneously.

The aim of this study was to investigate the feasibility of RPTNBD by comparing clinical outcomes before and after the introduction of this technique.

Methods {#Sec2}
=======

Study design and participants {#Sec3}
-----------------------------

This was a retrospective cohort study performed in a single institute. We reviewed the medical charts of patients who underwent pylorus-preserving PD (PPPD) or Whipple's operation for malignant disease between June 2012 and August 2016. Clinical outcomes of the patients were compared to those of internal controls. Internal controls included the patients who underwent PPPD or Whipple's operation due to malignant disease before June 2012. Percutaneous transhepatic biliary drainage (PTBD) was not inserted in these patients postoperatively. PTBD insertion was not technically feasible because the biliary system was compressed in these patients. Only percutaneous abscess drainage (PAD) was inserted to remove the digestive juice that leaked from anastomoses. Approval to perform research on human subjects in this study was provided by the Institutional Review Board of Korea University Medical Center Ansan Hospital (registration number: 2018AS0029). This study adhered to the tenets of the Declaration of Helsinki.

Procedures {#Sec4}
----------

The lymph nodes of the hepatoduodenal ligament, the celiac trunk, and the right side of the superior mesenteric artery were excised. We performed pancreaticoenteric resection, which included resection of the pancreatic head, duodenum, proximal jejunum (the first 15 cm from the ligament of Treitz), common bile duct, and gall bladder. The pancreas was divided with electrocautery, and the pancreatic duct was cut with Metzenbaum scissors. Bleeding of the cut surface was controlled by electrocauterization or suture ligation.

For pancreaticoenteric anastomosis, the divided jejunum was lifted through the mesocolon of the transverse colon (retrocolic approach). A duct-to-mucosa anastomosis was made between the pancreatic duct and the jejunal mucosa. A polyvinyl chloride (PVC) stent was inserted in the jejunal opening and pancreatic duct to stabilize the inner strength of the pancreaticoenteric anastomosis. Before starting CJ, we inserted a blunt-pointed probe into the cut bile duct. This probe was passed through the peripheral duct and pulled through the liver parenchyma. A PVC drain tube was docked to the blunt point of the probe and retracted through the cut bile duct (Fig. [1](#Fig1){ref-type="fig"}). An end-to-side anastomosis was made between the bile duct and the jejunum (distal from PJ). The retracted end of the PVC drain was inserted into the jejunum during CJ. The opposite end of the PVC drain was pierced through the abdominal wall and was connected to a low-vacuum silicone reservoir. The final scheme of RPTNBD is shown in Fig. [2](#Fig2){ref-type="fig"}. To restore the gastrointestinal continuity, Billroth II or Roux-en-Y reconstruction was performed. For Billroth II reconstruction, a Braun anastomosis was added.Fig. 1Surgical retrograde installation of percutaneous transhepatic negative-pressure biliary drainage. **a** The opening of the cut bile duct was identified for the insertion of a blunt-pointed probe. **b** The metal probe penetrated through the liver parenchyma. **c** A drainage tube was docked to the metal probe. **d** The drainage tube was retracted through the cut bile ductFig. 2Final scheme of retrograde installation of percutaneous transhepatic negative-pressure biliary drainage. CJ choledochojejunostomy, PJ pancreaticojejunostomy

Assessments {#Sec5}
-----------

Demographic, clinical, pathological, and therapeutic information was obtained from the medical records of the study participants. Outcomes, including the operation time, vascular reconstruction method, duration of postoperative hospital stay, time to the first semi-blend diet, and postoperative complications, were investigated. Postoperative complications were graded according to the Clavien-Dindo classification of surgical complications.

Analysis {#Sec6}
--------

Internal controls were defined as patients, who underwent PPPD or Whipple's operation for malignant disease without RPTNBD. Clinical, pathological, and therapeutic outcomes, including the incidence of PJ leakage, were compared between the study participants and the internal controls. In the present study, PJ leakage was defined as a drain output of any volume occurring on or after postoperative day 3 with an amylase level of at least three times the serum amylase levels \[[@CR6]\].

Statistical analyses {#Sec7}
--------------------

Patients with and without RPTNBD were compared using the chi-squared test or Fisher's exact test for categorical data and the Student's *t* test or Mann-Whitney *U* test for continuous data with abnormal distribution. In two-tailed tests, a *P* value \< 0.05 was considered statistically significant. Statistical analysis was performed using SPSS 24.0 (SPSS Inc., Chicago, IL, USA).

Results {#Sec8}
=======

Twenty-one patients underwent RPTNBD during PD for a malignant disease of the duodenum, common bile duct, or pancreas. The patients' demographics are presented in Table [1](#Tab1){ref-type="table"}. The mean age and BMI of the enrolled patients were 65.5 ± 11.2 years (range, 36--82 years) and 22.6 ± 4.1 kg/m^2^ (range, 15.3--33.3 kg/m^2^), respectively. Among the 21 enrolled patients, 13 (61.9%) underwent PPPD. The operation time was 412.0 ± 92.8 min (range, 240--600 min), and the duration of hospital stay was 39.4 ± 26.4 days (range, 13--105 days). The time to the first semi-blend diet was 8.4 ± 5.6 days (range, 3--31 days). The tumor size was 3.1 ± 1.2 cm (range, 1.1--5.4 cm). The numbers of retrieved and metastatic lymph nodes were 18.0 ± 8.1 (range, 2--36) and 1.6 ± 2.8 (range, 0--8), respectively. Thirteen patients showed postoperative morbidities. Among the 13 cases, 10 (47.6%) corresponded to a morbidity of Clavien-Dindo grade III or higher (Table [2](#Tab2){ref-type="table"}). Four patients underwent radiological interventions for fluid collection around the PJ or CJ sites (cases 7, 11, 14, and 16); however, tubographic images acquired via the RPTNBD pathway showed no association between PJ and the fluid collection. All the patients recovered with conservative treatment.Table 1Demographic data of the RPTNBD group in the present studyNumberAgeSexBMIASA scorePreoperative ENBDDiagnosis178Male23.4IIINoPancreatic head cancer256Male21.3IINoPancreatic head cancer382Male24.7IIINoPancreatic head cancer466Male23.3IIYesCBD cancer536Male17.9IINoPancreatic head cancer677Female20.7IIYesCBD cancer753Male21.2IINoKlatskin tumor875Male19.7IIIYesPancreatic head cancer960Male18.4IIIYesPancreatic head cancer1078Female27.8IINoPancreatic head cancer1168Male23.4IINoPancreatic head cancer1272Female15.3IIYesPancreatic head cancer1360Male20.7IINoPancreatic head cancer1471Male27.0IIYesAOV cancer1572Male24.3IINoCBD cancer1657Female33.3IIINoKlatskin tumor1768Male25.0IIINoCBD cancer1876Female26.2IINoAOV cancer1958Male19.3IIYesPancreatic head cancer2054Female17.7IIINoPancreatic head cancer2159Male24.2IINoCBD cancer*BMI* body mass index, *ASA* American Society of Anesthesiologists, *ENBD* endoscopic nasobiliary drainage, *CBD* common bile duct, *AOV* ampulla of VaterTable 2Clinicopathologic data of the RPTNBD group in the current studyNumberOperationVascular reconstructionOperation time (min)Hospital stay (day)Time to SBD (day)C-D classificationPathologyRLNMLN1PPPD.3501680NEC202PPPD.517276IIAC1453Whipple.4401560AC2104PPPD.340316IIAC2205PPPD.5171360AC1606PPPD.3801850AC2007HPD^a^.4503012IIIaXGC1508PPPDPV, RHA3602280AC1989PPPDPV, RHA360367IIIaACC10010PPPD.3505210IIIaAC26811PPPDPV49810431IIIaACC16012Whipple.3272350AC20013PPPD.3602070AC4114PPPD.330487IIIaAC15015WhipplePV47010510IIIaAC36616HPD^b^.6005611IIIaAC25117PPPD.570267IIIaAC10018PPPD.240658IIIaAC20019WhipplePV, CHA440467IIAC13120WhipplePV440523IIIaAC21421Whipple.3142270AC320*SBD* semi-blend diet, *C-D* Clavien-Dindo, *RLN* retrieved lymph nodes, *MLN* metastatic lymph nodes, *PPPD* pylorus-preserving pancreatoduodenectomy, *NEC* neuroendocrine carcinoma, *AC* adenocarcinoma, *HPD* hepatopancreatoduodenectomy, *XGC* xanthogranulomatous cholecystitis, *PV* portal vein, *RHA* right hepatic artery, *ACC* acinar cell carcinoma, *CHA* common hepatic artery^a^This patient underwent Whipple's operation and right hemi-hepatectomy^b^This patient underwent Whipple's operation, right hemi-hepatectomy, and S1 segmentectomy

The demographics of the internal control are presented in Table [3](#Tab3){ref-type="table"}. The mean age and BMI of the enrolled patients were 62.6 ± 11.4 years (range, 30--78 years) and 22.6 ± 3.5 kg/m^2^ (range, 17.2--32.4 kg/m^2^), respectively. Among the 31 patients in the internal control group, 20 (64.5%) underwent PPPD. The operation time was 420.2 ± 170.4 min (range, 267--1,015 min) and the duration of hospital stay was 30.3 ± 22.5 days (range, 9--118 days). The time to the first semi-blend diet was 12.0 ± 12.4 days (range, 4--61 days). The tumor size was 3.2 ± 1.4 cm (range, 0.8--5.8 cm). The numbers of retrieved and metastatic lymph nodes were 19.7 ± 6.7 (range, 4--36) and 1.5 ± 2.4 (range, 0--8), respectively. Twenty-two patients had postoperative morbidities. Among the 22 cases, 10 (52.4%) corresponded to a morbidity of Clavien-Dindo grade III or higher (Table [4](#Tab4){ref-type="table"}). As shown in Table [5](#Tab5){ref-type="table"}, the incidence of postoperative complications did not differ between the study participants and the internal controls (*P* = 0.494). However, the internal controls showed a higher incidence of PJ complications than the study participants (*P* = 0.020). Mortality occurred in the internal controls, although 12 (38.7%) patients with PJ complication underwent radiological interventions of PAD to remove the digestive juice leaked from the anastomoses. The internal control group showed higher morbidity and mortality rates than the RPTNBD group (Additional file [1](#MOESM1){ref-type="media"}).Table 3Demographic data of the internal controls in the present studyNumberAgeSexBMIASA scorePreoperative ENBDDiagnosis1Male6323.3IINoPancreatic head cancer2Male5218.8IINoCBD cancer3Female5932.4IIYesPancreatic head cancer4Female5724.1IINoCBD cancer5Male5121.0IINoPancreatic head cancer6Male5224.0IIYesPancreatic head cancer7Male4523.6INoDuodenal cancer8Male5018.8IIYesDuodenal cancer9Male7624.1IINoCBD cancer10Male6921.9IINoCBD cancer11Female7618.1IINoCBD cancer12Female7322.9IIIYesPancreatic head cancer13Female5723.4INoPancreatic head cancer14Male7521.3IIYesAOV cancer15Female7329.1IIYesCBD cancer16Male5326.6IINoPancreatic head IPMN17Female3017.2INoPancreatic head cancer18Male7425.7IINoPancreatic head cancer19Male6224.1IIIYesPancreatic head IPMN20Female7223.1IIINoPancreatic head cancer21Female5823.8IINoCBD cancer22Male7723.1IINoCBD cancer23Male7118.5IIYesPancreatic head cancer24Male5824.8IINoPancreatic head cancer25Male6618.7IIYesPancreatic head cancer26Male5018.2IINoAGC27Female6020.0IINoDuodenal GIST28Male5918.8IINoPancreatic head cancer29Male6525.3IIINoAOV cancer30Male7227.4IIYesCBD cancer31Female7819.8IIYesCBD cancer*BMI* body mass index, *ASA* American Society of Anesthesiologists, *ENBD* endoscopic nasobiliary drainage, *CBD* common bile duct, *AOV* ampulla of Vater, *IPMN* intraductal papillary mucinous neoplasm, *AGC* advanced gastric cancer, *GIST* gastrointestinal stromal tumorTable 4Clinicopathologic data of the patients in the internal controlNumberOperationVascular reconstructionOperation time (min)Hospital stay (day)Time to SBD (day)C-D classificationPathologyRLNMLN1Whipple.345426IIIaAC2202PPPD.2751560AC1413PPPD.2671490AC1904PPPD.3307039IIIbAC2605PPPD.4001460NEC1606PPPD.480668IIIaAC2247Whipple.3651270AC1308Whipple.765316IIIaAC1989PPPD.370970AC11010PPPD.3301570AC24811PPPD.3701712IIAC10012PPPD.3501570AC20013PPPD.3404433IVaNEC4114PPPD.505417IIIaAC18015PPPD.3102422IIAC36316PPPD.101530.VAC25117PPPD.57011861IIIbAC32018PPPD.4902313IIAC20019PPPD.2902315IIAC13020Whipple.355414IIAC21421PPPD.327316IIIaAC15022Whipple.362538VAC17023WhipplePV467319VAC21624PPPD.313238IIIaAC24025WhipplePV75510.VAC28426Whipple.650349IIAC18027Whipple.285195IIAC13028Whipple.3651960NEC21029Whipple.365237IIIaAC19430PPPD.3181970AC21131PPPD.297147IIAC290*SBD* semi-blend diet, *C-D* Clavien-Dindo, *RLN* retrieved lymph nodes, *MLN* metastatic lymph nodes, *PPPD* pylorus-preserving pancreatoduodenectomy, *NEC* neuroendocrine carcinoma, *AC* adenocarcinoma, *PV* portal veinTable 5Comparison of outcomes between the RPTNBD group and internal control groupRPTNBD group (*n* = 21)Internal control group (*n* = 31)*P*Age (years), means ± SD65.5 ± 11.262.6 ± 11.40.330Female (%)28.635.50.765BMI (kg/m^2^), means ± SD22.6 ± 4.122.6 ± 3.50.980PPPD (%)61.964.51.000Preoperative ENBD (%)33.335.51.000Operation time (min), means ± SD412.0 ± 92.8420.2 ± 170.40.843Hospital stay (days), means ± SD39.4 ± 26.430.3 ± 22.50.190Time to SBD (day), means ± SD8.4 ± 5.611.3 ± 11.70.307Vascular reconstruction (%)33.36.50.012Hepatectomy (%)9.53.20.339Postoperative PAD (%)19.045.20.076Fluid collection (%)19.06.50.207Anastomotic leakage (%)038.70.001Morbidity (%)61.971.00.494C-D grade \> II (%)47.645.21.000PJ complication (%)9.5^a^38.70.020Mortality (%)0.012.90.087*SD* standard deviation*, BMI* body mass index*, PPPD* pylorus-preserving pancreatoduodenectomy, *ENBD* endoscopic nasobiliary drainage*, SBD* semi-blend diet, *PAD* percutaneous abscess drainage, *C-D* Clavien-Dindo, *PJ* pancreaticojejunostomy^a^These patients had only fluid collection around PJ sites with no evidence of leakage in tubography

Discussion {#Sec9}
==========

Considering the results, we believe that RPTNBD might contribute to the salvage treatment of a morbidity after PD. Because the present study included far advanced cases that required some challenging procedures (i.e., major vessel reconstruction or simultaneous hepatectomy) to accomplish R0 resection, several cases carried a high risk of morbidity or mortality. However, most postoperative complications were managed with intravenous antibiotics and additional PAD. One patient who underwent portal vein and right hepatic artery reconstructions did not show any postoperative morbidity. It was remarkable that no mortality occurred even in the advanced cases that required technically demanding procedures.

Because the corrosive property of pancreatic juice might cause secondary catastrophes in the surgical field, several strategies have been designed to prevent pancreaticoenteric leakage after the introduction of PD. Although many strategies have been established for the postoperative safety of PD, biliary tract decompression is one of the most traditional methods that reduces the morbidity rate of PD. In 1935, Whipple et al. first proposed preoperative biliary drainage (PBD), by which obstructive jaundice could be corrected in patients with periampullary lesions \[[@CR7]\]. Preoperative correction of jaundice could be related to the clinical outcomes of patients undergoing PD, because hyperbilirubinemia is associated with impaired liver function, coagulation disorder, compromised immunity, accumulation of circulating endotoxin, and wound problems \[[@CR8]--[@CR11]\]. Currently, PBD has been facilitated by the technical advancement of radiological interventions (i.e., PTBD) and endoscopic procedures. With regard to the clinical outcomes of patients undergoing PD, some studies showed the benefits of PBD, including improved resection rate, morbidity, and mortality rates \[[@CR12], [@CR13]\]. However, other reports indicated drawbacks of this procedure. Several researchers reported the possibility of hyperamylasemia after radiological or endoscopic procedures \[[@CR14], [@CR15]\]. In addition, some comparative studies revealed that PBD caused certain morbidities rather than advantages in patients who underwent PD \[[@CR16], [@CR17]\]. Therefore, the benefit of performing PBD before PD is not yet established.

Biliary drainage can be performed intraoperatively. Doi et al. reported an intraoperative biliary decompression technique in which a newly developed curved drainage clamp (Mizuho Co., Tokyo, Japan) was used for the drainage of the common hepatic duct stump \[[@CR18]\]. However, it was difficult to determine the effect of this technique on anastomosis, despite the possibility that this technique reduces the risk of hepatic complications. As part of another biliary decompression technique, the special structures are added after PD. Two strategies were used for adding these special structures over the last few decades. Braun anastomosis is one of these two strategies; it reduces the pressure in the biliopancreatic limb to avoid the afferent loop syndrome. The result of a randomized clinical trial showed that Braun anastomosis might decrease the pressure in the biliopancreatic limb after standard Whipple's operation \[[@CR19]\]. Separating anastomoses is the other strategy. Isolated Roux loop PJ was performed to lower the incidence rate of pancreatic fistula \[[@CR20]\]. Double Roux-en-Y reconstruction was proposed to isolate pancreaticoenteric, choledochoenteric, or gastroenteric anastomosis \[[@CR21]\]. However, all these modified structures rendered no significant protection against pancreaticoenteric leakage \[[@CR19]--[@CR21]\].

When PJ failures are diagnosed postoperatively, several radiological interventions can be helpful in maintaining the conservative treatment. PTBD and PAD are the representative procedures that have been widely accepted in the clinical field. These interventions can minimize anastomotic soling. PTBD reduces biliary flow into the afferent loop, which effectively decreases pressure in the disrupted anastomosis. PAD, on the contrary, may remove the digestive juice that has already leaked from the PJ or CJ site. Currently, the conservative strategy for the management of PJ or CJ failure is usually composed of PTBD or PAD, when radiological interventions can be performed under the guidance of real-time imaging techniques. Although PTBD heals the failed anastomosis by reducing the leakage, this intervention depends on biliary imaging. If the biliary ducts are not dilated, postoperative PTBD is technically demanding. Therefore, we performed RPTNBD intraoperatively. Our novel method was designed by incorporating the advantages of the previous procedures. The biliary decompression effect of RPTNBD may be equal to that of PTBD; however, the former does not require radiological guidance. As RPTNBD is intraoperatively performed during PD, surgeons can insert the drainage tube into the biliary duct.

RPTNBD has a protective effect against anastomotic leakage in both PJ and CJ sites. Similar to PTBD, RPTNBD decreases the high pressure of the afferent loop resulting from the accumulation of bile or pancreatic juice, which inevitably occurs during the paralytic ileus period after PD. When a minor leakage occurs in the PJ or CJ site, RPTNBD can reduce the risk of anastomotic failure. Although PAD had to be applied for fluid collection around the PJ or CJ site in several cases (cases 7, 11, 14, and 16) in the present study, these morbidities did not lead to the fulminant failure of PJ or CJ. Their drain amylase levels did not exceed three times the serum amylase levels. Tubography is also possible via the RPTNBD route, which can facilitate making a critical decision in the postoperative course (Additional file [2](#MOESM2){ref-type="media"}). For example, although computed tomography implied complicated fluid collection around the pancreas in two cases (cases 7 and 11), in our study, we could confirm no connection between the fluid collection and PJ using tubography via RPTNBD. In such cases, tubography via RPTNBD could provide an important clue to avoid unnecessary delay of the clinical decision.

One limitation of RPTNBD is that the surgeon should have reliable knowledge regarding the hepato-biliary anatomy. This is also an important precondition for performing RPTNBD. Although we did not encounter any accidental hemorrhage, introducing a probe into the intrahepatic bile duct may harbor a risk of injury to the hepatic structures.

Conclusion {#Sec10}
==========

In conclusion, if a skilled surgeon performs RPTNBD, pancreaticoenteric anastomosis may be stabilized after PD. RPTNBD is expected to be effective in minimizing PJ or CJ anastomotic failure, which can arise in compromised patients.

Additional files
================

 {#Sec11}

Additional file 1:**Table S1.** Comparison of outcomes between RPTNBD group and internal controls with PAD related to anastomotic leakage. *SD* standard deviation*, BMI* body mass index*, PPPD* pylorus-preserving pancreatoduodenectomy, *ENBD* endoscopic nasobiliary drainage*, SBD* semi-blend diet, *PAD* percutaneous abscess drainage, *C-D* Clavien-Dindo, *PJ* pancreaticojejunostomy. (DOCX 26 kb) Additional file 2:**Figure S1.** Tubography showing each anastomosis via the route of retrograde installation of percutaneous transhepatic negative-pressure biliary drainage. *CJ* choledochojejunostomy, *PJ* pancreaticojejunostomy, *GJ* gastrojejunostomy. (PPTX 1740 kb)
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BMI

:   Body mass index

CJ

:   Choledochojejunostomy

PAD

:   Percutaneous abscess drainage

PBD

:   Preoperative biliary drainage

PD

:   Pancreaticoduodenectomy

PG

:   Pancreaticogastrostomy

PJ

:   Pancreaticojejunostomy

PPPD

:   Pylorus-preserving pancreaticoduodenectomy

PTBD

:   Percutaneous transhepatic biliary drainage

PVC

:   Polyvinyl chloride

RPTNBD

:   Retrograde installation of percutaneous transhepatic negative-pressure biliary drainage
